The role of GPCRs and homing molecules in the control and regionalization of mucosal immunity.
This project aims to investigate the role of GPCRs, particularly GPR35, in immune regionalization of mucosal tissues to enhance understanding and treatment of gut and airway diseases.
Projectdetails
Introduction
Mucosal immunity is essential to preserve homeostasis and for pathogen control within the gut and the airways. The emerging dogma of immune regionalization has opened new questions about which elements drive cell adaptation to different niches, and how this can be targeted to cure diseases.
Functional Diversity of Mucosal Tissues
The intestine and the airways are functionally diverse along their length, and disorders can differentially impact different mucosal tissue regions. Mucosa-associated lymphoid tissues (MALTs) are located along the intestine and the airways to drain selective tissue segments and support protective immunity.
Immune Regionalization and MALTs
Whether MALTs located in different tissue areas show immune regionalization remains poorly understood. Additionally, little is known about which molecules control such immune diversity.
Role of GPCRs
G protein-coupled receptors (GPCRs) are surface proteins important for cell migration and compartmentalization in lymphoid tissues, but their role in immune regionalization is not clear.
Proposed Methodology
We propose to apply a combination of imaging, flow cytometry, spatial gene editing, and sequencing techniques to study the role of GPCRs in immune regionalization of MALTs, at steady state and in disease.
Intestinal Analysis
In the intestine, we will:
- Phenotypically and functionally profile immune cells.
- Analyze GPCRs expression within Peyer's patches (PPs) from different gut regions, in physiology or in the context of inflammation and obesity.
Airway Analysis
Similarly, we will analyze immune regionalization of:
- Bronchus-associated lymphoid tissues.
- Nose-associated lymphoid tissues within the airways, at steady state or upon infections.
Characterization of GPR35
Finally, we will characterize the role of a candidate GPCR, GPR35, in the induction of intestinal and respiratory immunity. Our preliminary data show that GPR35 shapes cell recruitment to inflamed airways and influences cell positioning within PPs.
Conclusion
By applying the above-mentioned approaches and dedicated mouse models, we will study how GPR35 regulates mucosal immunity and if it represents an attractive clinical target.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.500.000 |
Totale projectbegroting | € 1.500.000 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITA VITA-SALUTE SAN RAFFAELEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Deciphering Antigen-Specific Circuits Orchestrating Tolerance.This project aims to uncover the cellular interactions governing peripheral regulatory T cell responses to gut microbes, enhancing understanding of tolerance mechanisms for treating inflammation-related conditions. | ERC Starting... | € 2.175.000 | 2024 | Details |
Development of a new therapeutic product targeting neuroimmune circuits to treat asthmaThe IMMCEPTION 2 project aims to develop a selective GPCRX antagonist to treat asthma by blocking neuroimmune circuits, potentially leading to a new oral medication for patients. | ERC Proof of... | € 150.000 | 2024 | Details |
Innate lymphoid cells and tissue adaptation to changing metabolic needsThis project aims to elucidate the role of ILC3 and the IL-22:IL-22BP module in intestinal adaptation to metabolic changes, with implications for understanding and treating metabolic diseases. | ERC Advanced... | € 2.379.266 | 2022 | Details |
T cell regulation by fed state bacterial metabolitesThis project aims to identify immunoregulatory bacterial molecules produced in response to food intake, enhancing understanding of gut microbiome tolerance mechanisms and their impact on intestinal health. | ERC Starting... | € 1.499.548 | 2024 | Details |
Deciphering host-gut microbiota spatio-functional plasticity in inflammationThis project aims to investigate the spatiofunctional plasticity of gut bacteria in Crohn's disease, exploring host-microbe interactions and their impact on inflammation using advanced microbiological and immunological methods. | ERC Starting... | € 1.997.500 | 2023 | Details |
Deciphering Antigen-Specific Circuits Orchestrating Tolerance.
This project aims to uncover the cellular interactions governing peripheral regulatory T cell responses to gut microbes, enhancing understanding of tolerance mechanisms for treating inflammation-related conditions.
Development of a new therapeutic product targeting neuroimmune circuits to treat asthma
The IMMCEPTION 2 project aims to develop a selective GPCRX antagonist to treat asthma by blocking neuroimmune circuits, potentially leading to a new oral medication for patients.
Innate lymphoid cells and tissue adaptation to changing metabolic needs
This project aims to elucidate the role of ILC3 and the IL-22:IL-22BP module in intestinal adaptation to metabolic changes, with implications for understanding and treating metabolic diseases.
T cell regulation by fed state bacterial metabolites
This project aims to identify immunoregulatory bacterial molecules produced in response to food intake, enhancing understanding of gut microbiome tolerance mechanisms and their impact on intestinal health.
Deciphering host-gut microbiota spatio-functional plasticity in inflammation
This project aims to investigate the spatiofunctional plasticity of gut bacteria in Crohn's disease, exploring host-microbe interactions and their impact on inflammation using advanced microbiological and immunological methods.